Bhavana Bhatnagar
Bhavana Bhatnagar
West Virginia Cancer Institute
Verified email at
Cited by
Cited by
Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology
JP Radich, M Deininger, CN Abboud, JK Altman, E Berman, R Bhatia, ...
Journal of the National Comprehensive Cancer Network 16 (9), 1108-1135, 2018
Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology
MW Deininger, NP Shah, JK Altman, E Berman, R Bhatia, B Bhatnagar, ...
Journal of the National Comprehensive Cancer Network 18 (10), 1385-1415, 2020
Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single†…
B Bhatnagar, S Gilmore, O Goloubeva, C Pelser, M Medeiros, S Chumsri, ...
Springerplus 3, 1-6, 2014
Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial
A El-Jawahri, TW LeBlanc, A Kavanaugh, JA Webb, VA Jackson, ...
JAMA oncology 7 (2), 238-245, 2021
XPO1 inhibition using selinexor synergizes with chemotherapy in acute myeloid leukemia by targeting DNA repair and restoring topoisomerase IIα to the nucleus
P Ranganathan, T Kashyap, X Yu, X Meng, TH Lai, B McNeil, ...
Clinical Cancer Research 22 (24), 6142-6152, 2016
NCCN guidelines insights: chronic myeloid leukemia, version 1.2017
A Pallera, JK Altman, E Berman, CN Abboud, B Bhatnagar, P Curtin, ...
Journal of the National Comprehensive Cancer Network 14 (12), 1505-1512, 2016
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
AS Kittai, DA Bond, B William, A Saad, S Penza, Y Efebera, K Larkin, ...
Blood Advances 4 (19), 4648-4652, 2020
Consolidation therapy with blinatumomab improves overall survival in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in measurable residual disease†…
MR Litzow, Z Sun, E Paietta, RJ Mattison, HM Lazarus, JM Rowe, ...
Blood 140 (Supplement 2), LBA-1-LBA-1, 2022
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia
P Ranganathan, X Yu, R Santhanam, J Hofstetter, A Walker, K Walsh, ...
Blood, The Journal of the American Society of Hematology 125 (17), 2689-2692, 2015
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia
B Bhatnagar, AK Eisfeld, D Nicolet, K Mrůzek, JS Blachly, S Orwick, ...
British journal of haematology 175 (2), 226-236, 2016
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy
B Bhatnagar, VH Duong, TS Gourdin, ML Tidwell, C Chen, Y Ning, ...
Leukemia & lymphoma 55 (7), 1533-1537, 2014
NCCN guidelines insights: acute lymphoblastic leukemia, Version 1.2019: featured updates to the NCCN guidelines
PA Brown, M Wieduwilt, A Logan, DJ DeAngelo, ES Wang, A Fathi, ...
Journal of the National Comprehensive Cancer Network 17 (5), 414-423, 2019
Poor survival and differential impact of genetic features of black patients with acute myeloid leukemia
B Bhatnagar, J Kohlschmidt, K Mrůzek, Q Zhao, JL Fisher, D Nicolet, ...
Cancer discovery 11 (3), 626-637, 2021
Complete responses in relapsed/refractory acute myeloid leukemia (AML) patients on a weekly dosing schedule of XmAb14045, a CD123 x CD3 T cell-engaging bispecific antibody†…
F Ravandi, A Bashey, JM Foran, W Stock, R Mawad, W Blum, MW Saville, ...
Blood 132, 763, 2018
AML with myelodysplasia-related changes: development, challenges, and treatment advances
KL Koenig, KD Sahasrabudhe, AM Sigmund, B Bhatnagar
Genes 11 (8), 845, 2020
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia
AR Walker, H Wang, K Walsh, B Bhatnagar, S Vasu, R Garzon, ...
Leukemia & lymphoma 57 (9), 2100-2108, 2016
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia
N Jain, W Stock, A Zeidan, E Atallah, J McCloskey, L Heffner, B Tomlinson, ...
Blood advances 4 (3), 449-457, 2020
Entospletinib in combination with induction chemotherapy in previously untreated acute myeloid leukemia: response and predictive significance of HOXA9 and MEIS1 expression
AR Walker, JC Byrd, JS Blachly, B Bhatnagar, AS Mims, S Orwick, TL Lin, ...
Clinical Cancer Research 26 (22), 5852-5859, 2020
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study
B Bhatnagar, Q Zhao, AS Mims, S Vasu, GK Behbehani, K Larkin, ...
Leukemia & lymphoma 61 (2), 387-396, 2020
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML
JY Jeon, Q Zhao, DR Buelow, M Phelps, AR Walker, AS Mims, S Vasu, ...
Investigational new drugs 38, 340-349, 2020
The system can't perform the operation now. Try again later.
Articles 1–20